Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has seen a significant appreciation of nearly 90% in its stock value over the past month, indicating strong market sentiment. The company’s advanced multi-cancer early detection blood test, underpinned by favorable results from the PATHFINDER 2 study and positive insights from key opinion leaders, suggests a promising outlook for gaining regulatory approval and accessing a substantial total addressable market estimated at approximately $3.7 billion in the UK by 2026. Additionally, GRAIL’s strategic partnerships and anticipated influx of over $400 million to its balance sheet enhance its financial outlook and position in the burgeoning early cancer detection market.

Bears say

GRAIL Inc has reported continuous significant net losses since its inception, with projections indicating that it will maintain this trend due to ongoing studies, regulatory approval efforts, and the necessity to expand its operational infrastructure. The company faces multiple risks, including potential delays in reimbursement pathways, adoption challenges for its innovative multi-cancer early detection test, and competitive threats from established diagnostics firms with more resources. Additionally, the expectation of rising Selling, General and Administrative (SG&A) expenses, coupled with possible financing shortfalls and setbacks in clinical study timelines, creates substantial concerns regarding GRAIL's ability to effectively commercialize its products.

GRAIL Inc (GRAL) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 3 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $115, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $115, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.